advertisement
Bell K 11
Showing records 1 to 11 | Display all abstracts from Bell K75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Pfeiffer N
PLoS ONE 2017; 12: e0188899
75168 Peptides of the variable IgG domain as potential biomarker candidates in primary open-angle glaucoma (POAG)
Schmelter C
Human Molecular Genetics 2017; 26: 4451-4464
75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Voykov B
PLoS ONE 2017; 12: e0188899
75168 Peptides of the variable IgG domain as potential biomarker candidates in primary open-angle glaucoma (POAG)
Perumal N; Funke S
Human Molecular Genetics 2017; 26: 4451-4464
75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Renieri G; Bell K
PLoS ONE 2017; 12: e0188899
75168 Peptides of the variable IgG domain as potential biomarker candidates in primary open-angle glaucoma (POAG)
Bell K
Human Molecular Genetics 2017; 26: 4451-4464
75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Richter P
PLoS ONE 2017; 12: e0188899
75168 Peptides of the variable IgG domain as potential biomarker candidates in primary open-angle glaucoma (POAG)
Pfeiffer N
Human Molecular Genetics 2017; 26: 4451-4464
75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Weigel M
PLoS ONE 2017; 12: e0188899
75168 Peptides of the variable IgG domain as potential biomarker candidates in primary open-angle glaucoma (POAG)
Grus FH
Human Molecular Genetics 2017; 26: 4451-4464
75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Thieme H; Wilhelm B; Lorenz K; Feindor M; Wosikowski K; Janicot M; Päckert D; Römmich R; Mala C; Fettes P; Leo E
PLoS ONE 2017; 12: e0188899
